155 related articles for article (PubMed ID: 24900881)
21. Kinesin spindle protein (KSP) inhibitors with 2,3-fused indole scaffolds.
Oishi S; Watanabe T; Sawada J; Asai A; Ohno H; Fujii N
J Med Chem; 2010 Jul; 53(13):5054-8. PubMed ID: 20521839
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Biphenyl-Type Inhibitors Targeting the Eg5 α4/α6 Allosteric Pocket.
Gao C; Lowndes NF; Eriksson LA
ACS Omega; 2017 May; 2(5):1836-1849. PubMed ID: 30023646
[TBL] [Abstract][Full Text] [Related]
23. Discovery of allosteric inhibitors of kinesin spindle protein (KSP) for the treatment of taxane-refractory cancer: MK-0731 and analogs.
Cox CD; Garbaccio RM
Anticancer Agents Med Chem; 2010 Nov; 10(9):697-712. PubMed ID: 21235439
[TBL] [Abstract][Full Text] [Related]
24. Conformation-dependent ligand regulation of ATP hydrolysis by human KSP: activation of basal hydrolysis and inhibition of microtubule-stimulated hydrolysis by a single, small molecule modulator.
Luo L; Carson JD; Molnar KS; Tuske SJ; Coales SJ; Hamuro Y; Sung CM; Sudakin V; Auger KR; Dhanak D; Jackson JR; Huang PS; Tummino PJ; Copeland RA
J Am Chem Soc; 2008 Jun; 130(24):7584-91. PubMed ID: 18491908
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and SAR of thiophene containing kinesin spindle protein (KSP) inhibitors.
Pinkerton AB; Lee TT; Hoffman TZ; Wang Y; Kahraman M; Cook TG; Severance D; Gahman TC; Noble SA; Shiau AK; Davis RL
Bioorg Med Chem Lett; 2007 Jul; 17(13):3562-9. PubMed ID: 17498954
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and evaluation of a novel prodrug, a S-trityl-
Fukai R; Ogo N; Ichida T; Yamane M; Sawada JI; Miyoshi N; Murakami H; Asai A
Eur J Med Chem; 2021 Apr; 215():113288. PubMed ID: 33640763
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors.
Mansoor UF; Angeles AR; Dai C; Yang L; Vitharana D; Basso AD; Gray K; Tang H; Liu M; Liang L; Allbritton O; Siddiqui MA
Bioorg Med Chem; 2015 May; 23(10):2424-34. PubMed ID: 25868746
[TBL] [Abstract][Full Text] [Related]
28. Structural basis of new allosteric inhibition in Kinesin spindle protein Eg5.
Yokoyama H; Sawada J; Katoh S; Matsuno K; Ogo N; Ishikawa Y; Hashimoto H; Fujii S; Asai A
ACS Chem Biol; 2015 Apr; 10(4):1128-36. PubMed ID: 25622007
[TBL] [Abstract][Full Text] [Related]
29. Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy.
Song H; Zhou S; Wang R; Li S
ChemMedChem; 2013 Nov; 8(11):1736-49. PubMed ID: 23964020
[TBL] [Abstract][Full Text] [Related]
30. Functional 1,3a,6a-triazapentalene scaffold: Design of fluorescent probes for kinesin spindle protein (KSP).
Sawada JI; Osawa A; Takeuchi T; Kaneda M; Oishi S; Fujii N; Asai A; Tanino K; Namba K
Bioorg Med Chem Lett; 2016 Dec; 26(23):5765-5769. PubMed ID: 27793568
[TBL] [Abstract][Full Text] [Related]
31. Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.
Matsuno K; Sawada J; Sugimoto M; Ogo N; Asai A
Bioorg Med Chem Lett; 2009 Feb; 19(4):1058-61. PubMed ID: 19167222
[TBL] [Abstract][Full Text] [Related]
32. Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domain.
Sheth PR; Shipps GW; Seghezzi W; Smith CK; Chuang CC; Sanden D; Basso AD; Vilenchik L; Gray K; Annis DA; Nickbarg E; Ma Y; Lahue B; Herbst R; Le HV
Biochemistry; 2010 Sep; 49(38):8350-8. PubMed ID: 20718440
[TBL] [Abstract][Full Text] [Related]
33. Characterization of inhibitor binding to human kinesin spindle protein by site-directed mutagenesis.
Marshall CG; Torrent M; Williams O; Hamilton KA; Buser CA
Arch Biochem Biophys; 2009 Apr; 484(1):1-7. PubMed ID: 19467625
[TBL] [Abstract][Full Text] [Related]
34. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
Ruan XQ; Chen M; Wu WT; You QD
Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and evaluation of tetrahydroisoquinolines as new kinesin spindle protein inhibitors.
Jiang C; You Q; Liu F; Wu W; Guo Q; Chern J; Yang L; Chen M
Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):567-71. PubMed ID: 19483335
[TBL] [Abstract][Full Text] [Related]
36. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB
Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792
[TBL] [Abstract][Full Text] [Related]
37. Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
Garbaccio RM; Tasber ES; Neilson LA; Coleman PJ; Fraley ME; Olson C; Bergman J; Torrent M; Buser CA; Rickert K; Walsh ES; Hamilton K; Lobell RB; Tao W; South VJ; Diehl RE; Davide JP; Yan Y; Kuo LC; Li C; Prueksaritanont T; Fernandez-Metzler C; Mahan EA; Slaughter DE; Salata JJ; Kohl NE; Huber HE; Hartman GD
Bioorg Med Chem Lett; 2007 Oct; 17(20):5671-6. PubMed ID: 17804233
[TBL] [Abstract][Full Text] [Related]
38. KSP inhibitors as antimitotic agents.
Pérez-Melero C
Curr Top Med Chem; 2014; 14(20):2286-311. PubMed ID: 25434354
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship of pyrazolo pyrimidine derivatives as inhibitors of mitotic kinesin Eg5 and anticancer agents.
Muthuraja P; Veeramani V; Prakash S; Himesh M; Venkatasubramanian U; Manisankar P
Bioorg Chem; 2019 Mar; 84():493-504. PubMed ID: 30594885
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of inhibition of human KSP by ispinesib.
Lad L; Luo L; Carson JD; Wood KW; Hartman JJ; Copeland RA; Sakowicz R
Biochemistry; 2008 Mar; 47(11):3576-85. PubMed ID: 18290633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
